Data support preserving access to accelerated approval drugs for the seriously ill   Commentary in the American Journal of Managed Care warns that restricting access to accelerated approval therapies has minimal budget implications, but poses significant harm to patients   March 30,

Sacrificing regular doctor visits in order to socially distance is not a good idea. Here’s why By KENNETH E. THORPE DECEMBER 6, 2020 7:00PM (UTC) Millions of Americans have postponed lifesaving screenings and other preventative care due to COVID-19, according to an

WASHINGTON, D.C. (November 20, 2020) The Partnership to Fight Chronic Disease has issued the following statement in response to the Trump Administration’s Final Rule to extend benefits of drug rebates to Medicare beneficiaries:   “Rebates lower drug costs for insurers, but

By Kenneth E. Thorpe President Trump has long promised to lower prescription drug prices. Unfortunately, two of his administration’s newest proposals would actually raise out-of-pocket costs and reduce access to medicines.   They must be scrapped before they do real